Executives
?
Cummings James F.
Chief Medical Officer
Vaxart, Inc.
US, South San Francisco [HQ]
CIK
1886760
Data Source
We automatically created this profile. The information was aggregated based on earnings call transcripts, insider forms and DEF 14A statements.
Latest Information
Shares :
326,801
Price per Share :
$0.74
Equivalence :
$241,832.74
Transaction History
-
F326,801 Shares After TransactionValue : $424,841.30$4,279.60Transaction Date : 03/28/24
-
Footnotes
-
-
Footnotes:#1 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested on March 28, 2024.
-
F248,058 Shares After TransactionValue : $176,121.18$22,300.39Transaction Date : 12/08/23
-
Footnotes
-
-
Footnotes:#1 This transaction is being reported late due to administrative oversight.#2 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 8, 2023.#3 This amount includes 41,367 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan.#4 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2024.#5 Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date.
-
F240,093 Shares After TransactionValue : $288,111.60$9,558.00Transaction Date : 02/02/24
-
Footnotes
-
-
Footnotes:#1 This transaction is being reported late due to administrative oversight.#2 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 8, 2023.#3 This amount includes 41,367 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan.#4 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2024.#5 Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date.
-
A330,093 Shares After TransactionValue : $n/a$0.0Transaction Date : 03/18/24
-
Footnotes
-
-
Footnotes:#1 This transaction is being reported late due to administrative oversight.#2 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of December 8, 2023.#3 This amount includes 41,367 shares acquired under the Vaxart, Inc. 2022 Employee Stock Purchase Plan.#4 Represents shares that have been withheld by the Issuer to satisfy its income tax and withholding and remittance obligations in connection with the net settlement of RSUs vested as of February 2, 2024.#5 Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of March 18, 2024, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date.
-
A88,750 Shares After TransactionValue : $n/a$0.0Transaction Date : 03/17/23
-
Footnotes
-
-
Footnotes:#1 Grant of shares upon vesting of restricted stock units, which shall fully vest on December 8, 2023.#2 Grant of shares upon vesting of restricted stock units. Twenty five percent of the shares underlying the award shall vest on each anniversary of the vesting commencement date of February 2, 2023, so that the restricted stock units would be fully vested on the fourth anniversary of the vesting commencement date.